Empowering Health and MedTech Founders to Scale Faster, Smarter
The Medilink Midlands Innovation Builder (MMIB) is a venture readiness programme developed in partnership with Christian Kumar, Medilink Midlands Entrepreneur in Residence. It supports ambitious health and medtech innovators in building commercially viable, scalable businesses through expert-led guidance, intensive sprint-based support, and direct investor exposure.
Our first cohort is currently underway, comprising a combined cohort of companies that are pre-revenue but investor-ready and seeking strategic scale and £1m+ investment. With selected ventures receiving focused support over an accelerated 1–2 month period ahead of Venture Day on 3 June 2025.
Support focuses on:
- Business model validation and risk reduction
- Market access and commercial growth strategy
- Investor readiness and pitching preparation
Each company is benefitting from:
- Investment readiness and due diligence support
- Clinical, regulatory and financial strategy development
- 1:1 mentoring from leading sector experts
- Peer-to-peer learning and ecosystem integration
- Market insight from strategic partners.
This intensive programme culminates in a high-profile pitch opportunity at Venture Day, designed to connect founders with a high-value network of investors and strategic partners.
Programme Structure
MMIB meets innovators at different stages of development through tailored support streams:
Academic Innovators
- Dedicated to researchers and academics with a concept ready to explore for commercialisation.
- Support delivered mainly online through the “Research to Revenue” module, led by Medilink Midlands Entrepreneur in Residence.
Emerging Commercial Innovators
- Designed for companies that are post-concept but pre-revenue.
- Suitable for applicants with an established business or initial funding (private or public).
- Focus on building a corporate strategy aligned with clinical development plans.
Scaling Commercial Ventures
- Targeted at trading companies seeking international scale through funding or strategic growth.
- Support includes board-level guidance and growth strategy development.
- Companies may be revenue-generating or preparing for a £5m+ Series A funding round.
Venture Day – 3 June 2025
Venture Day marks the pinnacle of MMIB support, hosted at the Birmingham offices of Mills & Reeve, a Medilink Midlands Patron. Selected ventures will pitch their innovations to a curated audience of leading investment funds, industry stakeholders, and ecosystem partners.
The event will feature:
- Live pitch presentations
- Networking opportunities with investors and sector leaders
- A showcase of MMIB’s impact and innovation pipeline
MMIB is a trusted venture due diligence and growth programme. It gives founders a practical, strategic pathway to investment and commercialisation, backed by an ecosystem of experts and partners.
Programme benefits include:
- Access to a 12-month Medilink Midlands membership
- Investor and partner introductions
- Strategic support from a wide network of sector specialists
Get in touch
We’re planning Cohort 2 for Winter 2025. To stay informed or express interest, contact us:
To take part, the MMIB costs £600+VAT for UK innovators, and £900+VAT for overseas companies.